TY - JOUR A1 - Kiefer, Thomas A1 - Krahl, Dorothea A1 - Osthoff, Kathrin A1 - Thuss-Patience, Peter A1 - Bunse, Jörg A1 - Adam, Ulrich A1 - Jansen, Marc H. A1 - Ott, Rudolf A1 - Pfitzmann, Robert A1 - Pross, Matthias A1 - Kohlmann, Thomas A1 - Daeschlein, Georg A1 - Buhlert, Hermann A1 - Völler, Heinz A1 - Hirt, Carsten T1 - Importance of Pancreatic Enzyme Replacement Therapy after Surgery of Cancer of the Esophagus or the Esophagogastric Junction JF - Nutrition and cancer : an international journal N2 - After surgical treatment of cancer of the esophagus or the esophagogastric junction we observed steatorrhea, which is so far seldom reported. We analyzed all patients treated in our rehabilitation clinic between 2011 and 2014 and focused on the impact of surgery on digestion of fat. Reported steatorrhea was anamnestic, no pancreatic function test was made. Here we show the results from 51 patients. Twenty-three (45%) of the patients reported steatorrhea. Assuming decreased pancreatic function pancreatic enzyme replacement therapy (PERT) was started or modified during the rehabilitation stay (in the following called STEA(+)). These patients were compared with the patients without steatorrhea and without PERT (STEA(-)). Maximum weight loss between surgery and rehabilitation start was 18 kg in STEA(+) patient and 15.3 kg in STEA(-) patients. STEA(+) patients gained more weight under PERT during the rehabilitation phase (3 wk) than STEA(-) patients without PERT (+1.0 kg vs. -0.3 kg, P = 0.032). We report for the first time, that patients after cancer related esophageal surgery show anamnestic signs of exocrine pancreas insufficiency and need PERT to gain body weight. Y1 - 2017 U6 - https://doi.org/10.1080/01635581.2017.1374419 SN - 0163-5581 SN - 1532-7914 VL - 70 IS - 1 SP - 69 EP - 72 PB - Routledge, Taylor & Francis Group CY - Abingdon ER - TY - GEN A1 - Kiefer-Trendelenburg, Thomas Hermann A1 - Völler, Heinz A1 - Nothroff, Jörg A1 - Schikora, Martin A1 - Bartels-Reinisch, Birgit A1 - Heyne, Karolin A1 - Daeschlein, Georg T1 - Prevalence of patients with multiresistant pathogens (MRP) in rehabilitation clinics T2 - Oncology Research and Treatment Y1 - 2017 SN - 2296-5270 SN - 2296-5262 VL - 40 SP - 198 EP - 198 PB - Karger CY - Basel ER - TY - JOUR A1 - Kiefer, Thomas A1 - Völler, Heinz A1 - Nothroff, Jörg A1 - Schikora, Martin A1 - von Podewils, Sebastian A1 - Sicher, Claudia A1 - Bartels-Reinisch, Birgit A1 - Heyne, Karolin A1 - Haase, Hermann A1 - Jünger, Michael A1 - Daeschlein, Georg T1 - Multiresistente Erreger in der onkologischen und kardiologischen Rehabilitation T1 - Multiresistant Pathogens in Oncological and Cardiological Rehabilitation - Results of a Surveillance Study in Brandenburg BT - Ergebnisse einer Surveillancestudie in Brandenburg JF - Die Rehabilitation : Zeitschrift für Praxis und Forschung in der Rehabilitation N2 - In der vorliegenden Studie wurde die Prävalenz der Besiedlung mit multiresistenten Keimen an 155 Patienten aus der onkologischen und 157 Patienten aus der kardiologischen Rehabilitation mittels mikrobiologischen Screenings untersucht. Dabei zeigten 4,5% der onkologischen und 4,5% der kardiologischen Rehabilitationspatienten eine Besiedlung mit multiresistenten Erregern. Am häufigsten wurden 2-MRGN und ESBL (2,9%) nachgewiesen. Onkologische Rehapatienten zeigten doppelt so hohe Prävalenzraten für 3-MRGN im Vergleich zu kardiologischen (2,6 und 1,3%). Insgesamt zeigen onkologische und kardiologische Rehabilitationspatienten vergleichsweise niedrige Prävalenzraten für multiresistente Krankenhauskeime. N2 - We investigated the prevalence of multidrug resistant pathogens in patients of oncologic and cardiologic rehabilitation units with 155 oncologic and 157 cardiologic patients undergoing microbiologic screening. It was found that 4.5 % of oncologic as well as cardiologic patients were colonized with multidrug resistant pathogens. 2-MRGN and ESBL were the most encountered species (2.9 %). 3-MRGN were found twice as frequent in oncologic patients (2.6 and 1.3 %). Overall oncologic and cardiologic patients exhibit comparatively low prevalence rates for multidrug resistant pathogens. KW - Oncologic cardiologic rehabilitation KW - multiresistant bacteria KW - Onkologische kardiologische Rehabilitation KW - multiresistente Erreger Y1 - 2019 U6 - https://doi.org/10.1055/a-0638-9226 SN - 0034-3536 SN - 1439-1309 VL - 58 IS - 2 SP - 136 EP - 142 PB - Thieme CY - Stuttgart ER - TY - JOUR A1 - Kiefer, Thomas A1 - Krahl, Dorothea A1 - Hirt, Carsten A1 - Völler, Heinz A1 - Voelkel, Lorenz A1 - Daeschlein, Georg T1 - Influence of treatment caused impairments on anxiety and depression in patients with cancer of the Esophagus or the Esophagogastric junction JF - Journal of gastrointestinal cancer N2 - Purpose After therapy of cancer of the esophagus or the esophagogastric junction, patients often suffer from anxiety and depression. Some risk factors for elevated anxiety and depression are reported, but the influence of steatorrhea, the frequency of which has only recently been reported, has not yet been investigated. Method Using the Hospital Anxiety and Depression Scale (HADS), we analyzed the correlation of anxiety and depression with steatorrhea, appetite, and weight loss in 72 patients with cancer of the esophagus or of the esophagogastric junction, who were treated at our rehabilitation clinic between January 2011 and December 2014. In addition, effectiveness of psychological interviews was analyzed. Results We have evaluable anxiety questionnaires from 51 patients showing a median anxiety value of 5 (range 0-13). As for the depression, results from evaluable questionnaires of 54 patients also showed a median value of 5 (range 0-15). Increased anxiety and depression values (> 7) were observed in 25.4% and 37.0% of the patients respectively. Patients who were admitted with steatorrhea for rehabilitation showed a statistically higher anxiety value (median 6.3 vs. 4.7, p < 0.05), reduced appetite, and a weight loss above 15 kg depicting a correlation to anxiety and depression. Psychological conversations helped lowering the depression but had no influence on anxiety. Conclusions Impairments after cancer treatment, such as steatorrhea, appetite loss, and weight loss, should be interpreted as an alarm signal and should necessitate screening for increased anxiety and depression. Psychological therapy can help improving the extent of the depression. KW - Anxiety KW - Depression KW - Esophagus carcinoma KW - Exocrine pancreas KW - insufficiency KW - Rehabilitation KW - Steatorrhea Y1 - 2019 U6 - https://doi.org/10.1007/s12029-018-00193-7 SN - 1941-6628 SN - 1941-6636 VL - 51 IS - 1 SP - 30 EP - 34 PB - Springer CY - New York ER -